Japan approves two more COVID vaccines as fourth infection wave hitsJapan has approved two more coronavirus vaccines, while expanding a state of emergency to cover the southern island Share XJapan approves two more COVID vaccines as fourth infection wave hitshttps://pharmaphorum.com/news/japan-approves-two-more-covid-vaccines-as-fourth-infection-wave-hits/
Sanofi/GSK move latecomer COVID-19 shot into phase 3Sanofi and GlaxoSmithKline seem to be getting somewhere with their COVID-19 vaccine at last, announcing plans to move Share XSanofi/GSK move latecomer COVID-19 shot into phase 3https://pharmaphorum.com/news/sanofi-gsk-move-latecomer-covid-19-shot-into-phase-3/
UK government rethinks plans to buy AZ antibody doses – reportThe UK government has got cold feet over plans to buy a million doses of AstraZeneca’s antibody treatment Share XUK government rethinks plans to buy AZ antibody doses – reporthttps://pharmaphorum.com/news/uk-government-rethinks-plans-to-buy-1m-az-antibody-doses-report/
Novavax delays COVID vaccine filings until Q3Novavax has finally provided some clarity about when its long-awaited COVID-19 vaccine will be ready, saying regulatory filings Share XNovavax delays COVID vaccine filings until Q3https://pharmaphorum.com/news/novavax-delays-covid-vaccine-filings-until-q3-blaming-lack-of-manufacturing-data/
FDA authorises Pfizer/BioNTech vaccine for adolescentsThe FDA has authorised Pfizer/BioNTech’s vaccine for 12- to 15 year-olds under emergency rules. In a statement the Share XFDA authorises Pfizer/BioNTech vaccine for adolescentshttps://pharmaphorum.com/news/fda-authorises-pfizer-biontech-vaccine-for-adolescents/
Coronavirus won’t be circulating in UK by August, says outgoing vaccine chief Clive DixCoronavirus won’t be circulating in the UK by August, according to the outgoing chief of the country’s vaccine Share XCoronavirus won’t be circulating in UK by August, says outgoing vaccine chief Clive Dixhttps://pharmaphorum.com/news/outgoing-vaccine-chief-clive-dix/
Pfizer shares slump as support grows for COVID-19 vaccine patent waiverShares in COVID-19 vaccine manufacturers have taken a hit after the US signalled its support for waiving patents Share XPfizer shares slump as support grows for COVID-19 vaccine patent waiverhttps://pharmaphorum.com/news/pfizer-shares-slump-as-support-grows-for-covid-19-vaccine-patent-waiver/
EU starts rolling review of Sinovac’s COVID-19 vaccineEurope’s regulator has begun a rolling review of Sinovac’s COVID-19 vaccine, known as Vero Cell. The vaccine is Share XEU starts rolling review of Sinovac’s COVID-19 vaccinehttps://pharmaphorum.com/news/eu-regulator-begins-review-of-sinovacs-covid-19-vaccine/
UK orders 60m ‘booster’ doses of Pfizer/BioNTech COVID vaccineThe UK has ordered an extra 60 million doses of the Pfizer/BioNTech COVID-19 vaccine, which could be used Share XUK orders 60m ‘booster’ doses of Pfizer/BioNTech COVID vaccinehttps://pharmaphorum.com/news/uk-orders-60m-booster-doses-of-pfizer-biontech-covid-vaccine/
